These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1353 related items for PubMed ID: 17182241

  • 1. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P, European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [Abstract] [Full Text] [Related]

  • 2. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P.
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [Abstract] [Full Text] [Related]

  • 3. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH.
    Drugs; 2007 Oct; 67(2):175-94. PubMed ID: 17284083
    [Abstract] [Full Text] [Related]

  • 4. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
    Kaufner L, von Heymann C, Henkelmann A, Pace NL, Weibel S, Kranke P, Meerpohl JJ, Gill R.
    Cochrane Database Syst Rev; 2020 Aug 13; 8(8):CD012451. PubMed ID: 32790892
    [Abstract] [Full Text] [Related]

  • 6. Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.
    Ots PM, Pérez AR, Carrizosa CL, Ocaña CV, de Dios Sáez Garrido J, Delgado Pérez JM.
    Clin Transl Oncol; 2005 Dec 13; 7(11):486-92. PubMed ID: 16373059
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR.
    Med Oncol; 1998 Aug 13; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [Abstract] [Full Text] [Related]

  • 8. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
    Cheer SM, Wagstaff AJ.
    Drugs; 2004 Aug 13; 64(3):323-46. PubMed ID: 14871172
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct 13; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 15. Phase III clinical trials with darbepoetin: implications for clinicians.
    Glaspy J.
    Best Pract Res Clin Haematol; 2005 Oct 13; 18(3):407-16. PubMed ID: 15792914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
    Mafodda A, Giuffrida D, Prestifilippo A, Azzarello D, Giannicola R, Mare M, Maisano R.
    Support Care Cancer; 2017 Sep 13; 25(9):2779-2786. PubMed ID: 28391437
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice.
    Pujade-Lauraine E, Richard AJ, Sapède C, Hayward C.
    Oncol Rep; 2005 Oct 13; 14(4):1037-44. PubMed ID: 16142369
    [Abstract] [Full Text] [Related]

  • 19. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.
    Oncologist; 2004 Oct 13; 9(1):90-6. PubMed ID: 14755018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.